Biology of GVHD: Emerging Targets and Clinical Implications

Track: BMT Clinical Education Conference (for NPs, PAs, Fellows and Junior Faculty)
Saturday, March 1, 2014, 2:45 PM-3:30 PM
Grapevine B (Gaylord Texan)
John Koreth, MBBS, DPhil , Dana-Farber Cancer Institute, Boston, MA
Disclosures:
J. Koreth, Takeda Pharmaceuticals, not sure what you mean: Consultancy
Millennium Pharmaceuticals, not sure what you mean: Advisory Board and Research Funding
Prometheus Labs Inc, not sure what you mean: Research Funding
Eleven Biotherapeutics, not sure what you mean: Consultancy
Otsuka Pharmaceuticals, not sure what you mean: Research Funding
Spectrum Pharmaceuticals, not sure what you mean: Advisory Board
See more of: (CEC) Biology of GVHD Focusing on Emerging Targets and Clinical Implications (Bench to Bedside)
See more of: BMT Clinical Education Conference (for NPs, PAs, Fellows and Junior Faculty)